Clinical significance of machine learning algorithm in predicting PPM during TAVR in small annuli

Read full text
Authors: Yu Mao, Yang Liu, MengEn Zhai, Ping Jin, W. W. L. Li, Fangyao Chen, Yuhui Yang, Gejun Zhang, Jian Liu, Yingqiang Guo, Xiangbin Pan, Yongjian Wu
+1 more Jian Yang
Cited by: 0
References: 21

Abstract

Abstract Compared with left heart catheterization (LHC), the pressure gradient of an aortic valve (PG AV ) measured by echocardiography during transcatheter aortic valve replacement (TAVR) in small annuli is overestimated. The purpose of this study was to improve the accuracy of PG AV measurements by echocardiography in small annuli and to evaluate the influence of PG AV on prognosis. The internal derivation cohort included 273 consecutive patients with aortic stenosis and a small annulus (computed tomographic scan showing an annulus circumference < 72 mm or area < 400 mm 2 ) who underwent TAVR. Patients completed transthoracic echocardiography (TTE) and LHC measurements during TAVR, and an extreme gradient boosting (XGBoost) algorithm was trained. The primary outcome was a composite end point of all-cause mortality and readmission for heart failure. The mean PG AV level measured by TTE was overestimated compared to the LHC measurement {52.5 [interquartile range: 47.5–57.0] mmHg vs. 42.5 (interquartile range: 38.0–46.0) mmHg, P < 0.001}. After adjustments to the XGBoost, the mean PG AV measured by TTE could be significantly improved [Pearson correlation coefficient = 0.94, P < 0.001]. Importantly, patients with a predicted mean PG AV ≥ 68.6 mmHg showed a significantly increased incidence of composite end points at 2 years after the procedures (40.7% vs. 16.0%, P < 0.001). The XGBoost model could effectively improve the accuracy of the mean PG AV measured by TTE during TAVR, and the predicted mean increase in the PG AV level may lead to a worse prognosis. Clinical Trial Registration: ClinicalTrials.gov Protocol Registration System (NCT05044338). Graphical Abstract

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Cardiovascular Function and Risk Factors Cardiovascular Health and Disease Prevention

Publication details

Journal / source
Cardiovascular Intervention and Therapeutics
Volume
41
Issue
2
Pages
402–413
Publication date
5 January 2026
Language
EN